Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
about
Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in miceTreatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two childrenFrom bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamstersNew methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation.Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology.Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium.Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.Immunotherapy of rheumatoid arthritis.The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxisHumanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.Cytapheresis with a filter for selective removal of CD4+ T cells in experimental autoimmune encephalomyelitis.Monoclonal antibodies in the treatment of rheumatoid arthritis.A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis.Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells.Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.Use of anti-thymocyte globulin in the management of refractory systemic autoimmune diseases.
P2860
Q30982756-134FDAC0-575A-4A32-9CE8-9ACE834CAB82Q33578439-A910D888-6E76-4E12-8B77-07B883A403EDQ34321820-48892041-C74B-4293-A1F3-1E51B24E8375Q35456712-9405ECD2-1A94-48B4-B931-12F68353C7C5Q35546870-5C50BF41-0262-424E-AA9F-F79F667B971BQ35548626-3495AB51-8DD4-4B0D-A14B-B9842692F6C0Q35604657-6ED46D14-EDCF-47AA-9975-158847D75F83Q35621250-A0E3D8EE-0F7B-4086-94D7-8044CABEF026Q35881647-6C6F1121-9443-4C25-8601-D62F079DD953Q37297651-4AD6BEFC-4FE7-48FA-A792-07790785AD75Q39452477-4C84F982-2E98-4B8C-86B6-2971B5377DD8Q40609144-4769CC9C-5BD3-4832-BC18-6DDC6D6818AEQ40693747-CDC87832-CA2C-49D0-B407-F923CF7F10FAQ40794894-F7B1B34F-397A-4908-BE7D-FCCDCDFE141EQ40901167-01094F67-2016-4AF4-9E84-ED74A1A45B4BQ41496614-51D61B9A-5927-4EB7-AECE-7840046045F6Q54056758-64F8BE00-5FA4-4FE9-B213-6534CCD79413Q54253553-DA98F177-B4D9-4DC6-91ED-5D3F89BD1581
P2860
Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Treatment of rheumatoid arthri ...... uding repeated administration.
@en
Treatment of rheumatoid arthri ...... uding repeated administration.
@nl
type
label
Treatment of rheumatoid arthri ...... uding repeated administration.
@en
Treatment of rheumatoid arthri ...... uding repeated administration.
@nl
prefLabel
Treatment of rheumatoid arthri ...... uding repeated administration.
@en
Treatment of rheumatoid arthri ...... uding repeated administration.
@nl
P2093
P356
P1476
Treatment of rheumatoid arthri ...... uding repeated administration.
@en
P2093
Kakavand B
Riethmüller G
Schattenkirchner M
P304
P356
10.1002/ART.1780340504
P577
1991-05-01T00:00:00Z